What does APOTHEEK URSEL do?

APOTHEEK URSEL is a pharmacy in Aalter. Private Limited, started on 28 June 2010, 1 establishment.

What is the address of APOTHEEK URSEL?

The registered office of APOTHEEK URSEL is located at Urselseweg 259, 9910 Aalter.

Is APOTHEEK URSEL still active?

Yes. According to the CBE (30 October 2026) APOTHEEK URSEL is active, legal situation “Normale toestand”, started on 28 June 2010.

Is APOTHEEK URSEL registered on Peppol?

Yes, APOTHEEK URSEL is registered on the Peppol network with ID 0208:0827005865.

What is the enterprise number of APOTHEEK URSEL?

The enterprise number of APOTHEEK URSEL is BE0827005865.

When was APOTHEEK URSEL founded?

APOTHEEK URSEL was founded on 28 June 2010.

Who are the directors of APOTHEEK URSEL?

According to the 2025 annual accounts, the directors of APOTHEEK URSEL are: Dedeyne Bruno BV.

Is APOTHEEK URSEL a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 28 June 2010; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did APOTHEEK URSEL make in 2025?

APOTHEEK URSEL posted a profit after taxes of € 118,542 in financial year 2025.

What is the revenue of APOTHEEK URSEL?

As a small company, APOTHEEK URSEL is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 175,980.

APOTHEEK URSEL (Private Limited) - Aalter - BE0827005865

Dossier APOTHEEK URSEL, printed on 30 October 2026 from databakkes.be/en/0827005865/apotheek-ursel. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Tight liquidity NBB

Cash and receivables cover 23 % of short-term debt in 2025; threshold 65 %.

Financials

Financial year 2025

APOTHEEK URSEL from Aalter, company number BE0827005865, closed financial year 2025 with a result of € 118,542 after tax. For that financial year APOTHEEK URSEL recorded a gross margin of € 175,980 and equity of € 209,491. Compared with financial year 2024, the result moved from € 144,177 to € 118,542. The company is profitable. The company holds a healthy buffer. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on June 29, 2026.

What it is worth Healthy

€ 209,491

▼ 1% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 118,542

▼ 18% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 67,573

▼ 14% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 120,000 paid out

More than the year’s profit went to the shareholders; reserves fell.

People and assets in 2025

Vehicles and equipment

€ 1,784

▼ 33% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 4 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 435,732

▼ 23% vs 2024

€ 104,241 is repaid this year. At this pace the long-term loan is gone in ≈ 4 years.

Owed to suppliers

€ 191,039

▲ 54% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 3,470

▲ 58% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 164,339 Gross margin 2022: € 164,339 First fiscal year in the series	€ 183,055 Gross margin 2023: € 183,055 ▲ 11% vs 2022 (€ 164,339) Favourable step	€ 208,596 Gross margin 2024: € 208,596 ▲ 14% vs 2023 (€ 183,055) Favourable step	€ 175,980 Gross margin 2025: € 175,980 ▼ 16% vs 2024 (€ 208,596) Unfavourable step	▼ 16%
Profit after taxes	€ 97,226 Profit after taxes 2022: € 97,226 First fiscal year in the series	€ 105,273 Profit after taxes 2023: € 105,273 ▲ 8% vs 2022 (€ 97,226) Favourable step	€ 144,177 Profit after taxes 2024: € 144,177 ▲ 37% vs 2023 (€ 105,273) Favourable step	€ 118,542 Profit after taxes 2025: € 118,542 ▼ 18% vs 2024 (€ 144,177) Unfavourable step	▼ 18%
Equity	€ 209,499 Equity 2022: € 209,499 First fiscal year in the series	€ 210,771 Equity 2023: € 210,771 ▲ 1% vs 2022 (€ 209,499) Favourable step	€ 210,948 Equity 2024: € 210,948 Unchanged (€ 210,771) Favourable step	€ 209,491 Equity 2025: € 209,491 ▼ 1% vs 2024 (€ 210,948) Unfavourable step	▼ 1%
Total debts	€ 1,552,282 Total debts 2022: € 1,552,282 First fiscal year in the series	€ 1,491,276 Total debts 2023: € 1,491,276 ▼ 4% vs 2022 (€ 1,552,282) Favourable step	€ 1,436,673 Total debts 2024: € 1,436,673 ▼ 4% vs 2023 (€ 1,491,276) Favourable step	€ 1,498,251 Total debts 2025: € 1,498,251 ▲ 4% vs 2024 (€ 1,436,673) Unfavourable step	▲ 4%
Cash	€ 121,225 Cash 2022: € 121,225 First fiscal year in the series	€ 98,004 Cash 2023: € 98,004 ▼ 19% vs 2022 (€ 121,225) Unfavourable step	€ 78,785 Cash 2024: € 78,785 ▼ 20% vs 2023 (€ 98,004) Unfavourable step	€ 67,573 Cash 2025: € 67,573 ▼ 14% vs 2024 (€ 78,785) Unfavourable step	▼ 14%
Land & buildings	€ 517,268 Land & buildings 2022: € 517,268 First fiscal year in the series	€ 488,901 Land & buildings 2023: € 488,901 ▼ 5% vs 2022 (€ 517,268) Unchanged	€ 462,893 Land & buildings 2024: € 462,893 ▼ 5% vs 2023 (€ 488,901) Unchanged	€ 434,007 Land & buildings 2025: € 434,007 ▼ 6% vs 2024 (€ 462,893) Unchanged	▼ 6%
Retained profit	€ 190,899 Retained profit 2022: € 190,899 First fiscal year in the series	€ 192,171 Retained profit 2023: € 192,171 ▲ 1% vs 2022 (€ 190,899) Favourable step	€ 192,348 Retained profit 2024: € 192,348 Unchanged (€ 192,171) Favourable step	€ 190,891 Retained profit 2025: € 190,891 ▼ 1% vs 2024 (€ 192,348) Unfavourable step	▼ 1%
Dividend	€ 95,000 Dividend 2022: € 95,000 First fiscal year in the series	€ 104,000 Dividend 2023: € 104,000 ▲ 9% vs 2022 (€ 95,000) Unchanged	€ 144,000 Dividend 2024: € 144,000 ▲ 38% vs 2023 (€ 104,000) Unchanged	€ 120,000 Dividend 2025: € 120,000 ▼ 17% vs 2024 (€ 144,000) Unchanged	▼ 17%
Bank debt	€ 816,572 Bank debt 2022: € 816,572 First fiscal year in the series	€ 695,075 Bank debt 2023: € 695,075 ▼ 15% vs 2022 (€ 816,572) Favourable step	€ 564,878 Bank debt 2024: € 564,878 ▼ 19% vs 2023 (€ 695,075) Favourable step	€ 435,732 Bank debt 2025: € 435,732 ▼ 23% vs 2024 (€ 564,878) Favourable step	▼ 23%
Balance sheet total	€ 1,761,781 Balance sheet total 2022: € 1,761,781 First fiscal year in the series	€ 1,702,047 Balance sheet total 2023: € 1,702,047 ▼ 3% vs 2022 (€ 1,761,781) Unchanged	€ 1,647,622 Balance sheet total 2024: € 1,647,622 ▼ 3% vs 2023 (€ 1,702,047) Unchanged	€ 1,707,741 Balance sheet total 2025: € 1,707,741 ▲ 4% vs 2024 (€ 1,647,622) Unchanged	▲ 4%

Key figures of APOTHEEK URSEL, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to APOTHEEK URSEL?

What happened at APOTHEEK URSEL in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jun 29, 2026 New annual accounts for financial year 2025: profit of € 118,542 (▼ 18% vs 2024). Source: NBB ↗
Aug 13, 2010 New establishment in Aalter. KBO
Jun 28, 2010 Start of the company according to the CBE. KBO

In short

From € 97,226 profit in 2022 to € 118,542 profit in 2025.

Paid € 15,044 in corporate taxes since 2022.

Best year ever: 2024, with € 144,177 profit.

Paid out € 463,000 in dividends to the owners in total.

Original PDFs at the National Bank ↗

Management

DEDEYNE BRUNO 100%

The stake of DEDEYNE BRUNO comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.

APOTHEEK URSEL

Behind APOTHEEK URSEL is Dedeyne Bruno BV. The shares are held by DEDEYNE BRUNO (100%).

Directors

According to the 2025 annual accounts

Dedeyne Bruno BV

Director · represented by Bruno Dedeyne

Also active at: APOTHEEK DEDEYNE

Shareholders

DEDEYNE BRUNO

100%

Participations

No participations in other companies reported.

Establishments

Establishment units

Physical locations of this company

Registered office

Urselseweg 259

9910 Aalter

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0827.005.865
VAT number: BE 0827.005.865
Registered office: Urselseweg 259, 9910 Aalter
Names & denominations: APOTHEEK URSEL
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 28 June 2010
Peppol: Active · Active since 5 Nov 2025
Activities · NACE: Detailhandel in farmaceutische producten

View on CBE Public ↗ Annual accounts (NBB) ↗